SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following an earnings report that eased AI bubble fears and showcased strong revenue growth, particularly in its data center segment. The community is debating the sustainability of this growth, questioning accounting practices and revenue recognition, while also anticipating potential impact from a White House request regarding chip exports to China. Bullish sentiment prevails, with some analysts predicting further climbs, while others remain cautious, citing macro risks.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is gaining traction as community members rally around the revival of OG memes and a shared vision for the project's future. There's excitement around the strong community being built and references to the potential for significant growth, with many expressing long-term bullish sentiment. The community emphasizes building, grinding, and continuing to work even during red days.

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Corp

GeneDx is trending as community members assess the impact of new coverage from Piper Sandler and Canaccord Genuity, with price targets ranging from $155-$160. Recent news and strong earnings have generated discussion around the company's growth potential and possible disruptor status, while some traders are closely watching the chart setup for potential breakout opportunities and technical brilliance. Meanwhile, other investors are evaluating its high valuation and potential issues related to profitability and Medicaid.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals ($AGIO) is trending downwards after mixed results from its sickle cell disease drug trial sparked uncertainty about its regulatory path, leading to a significant stock plunge. Bullish analysts are split with some citing precedent for FDA approval, while the community debates the impact of missed endpoints and considers potential opportunities for competitors. Discussions also involve the company's cash position and upcoming PDUFA date for thalassemia.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending as investors monitor factors including the potential end of the government shutdown and its impact on economic data. Community discussions revolve around market volatility and possible opportunities in sectors like healthcare, with some expressing caution about an overvalued market. Nvidia's potential influence and the Federal Reserve's upcoming decisions are also key talking points.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective (INJ) is trending due to community excitement around the potential of leveraging its ecosystem with memecoins, specifically $NONJA. The community believes $NONJA offers high liquidity and upside potential, acting as a leveraged bet on the broader INJ ecosystem. This strategy is driven by the perception that memes on Injective move quickly and can offer outsized returns.

ETF Opportunities Trust - T-Rex 2X Long NVIDIA Daily Target ETF

T-Rex 2X Long NVIDIA Daily Target ETF

T-Rex 2X Long NVIDIA Daily Target ETF ($NVDX) is trending amid discussions around NVIDIA's earnings and its impact on the AI ecosystem. The community is actively analyzing earnings results, strategizing trades with leveraged ETFs, and debating future movements. Bullish sentiment is fueled by confidence in NVIDIA's long-term growth and dominance in the AI sector, while some traders express caution regarding the ETF's decay and potential market volatility.

GraniteShares ETF Trust - GraniteShares 2x Long NVDA Daily ETF

GraniteShares 2x Long NVDA Daily ETF

GraniteShares 2x Long NVDA Daily ETF (NVDL) is trending as traders analyze the potential impact of recent news on NVDA's earnings and future growth. The community is actively discussing strategies using leveraged ETFs to capitalize on potential after-hours moves and overall market sentiment around AI and semiconductor stocks. Some traders express bullish sentiment, anticipating a gap up after earnings, while others are cautious, considering potential pullbacks and hedging their positions.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Recent discussion around CRWV is largely focused on a potential sympathy play following strong earnings from NVDA, with many anticipating a short squeeze. Community sentiment is mixed, with some citing the company's debt and potential for high growth, while others highlight potential overvaluation and supply chain concerns. Michael Burry's past comments on GPU depreciation are also being debated in relation to CRWV's prospects.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings is experiencing high volatility as traders discuss a potential short squeeze, citing a low float and significant short interest. Community members are actively tracking volume and VWAP, anticipating a breakout and comparing the situation to previous meme stock rallies. The stock's movement is also linked to upcoming corporate events, with some traders setting price targets based on these potential catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Floyd Petersen Sells 16,679 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd Petersen sold 16,679 shares of the stock in a transaction that occurred on Thursday, November 13th. The shares were sold...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Floyd Petersen Sells 16,679 Shares

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd Petersen sold 16,679 shares of Amphastar Pharmaceuticals stock in a transaction dated Thursday, November 13th. The stock...

21,199 Shares in Amphastar Pharmaceuticals, Inc. $AMPH Acquired by Fox Run Management L.L.C.

Fox Run Management L.L.C. purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the second quarter, according to the company in its most recent...

Validea Peter Lynch Strategy Daily Upgrade Report - 11/11/2025

The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Issues Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Amphastar Pharmaceuticals (NASDAQ:AMPH - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.93 EPS for the quarter, beating analysts' consensus estimates of...

Y Intercept Hong Kong Ltd Purchases Shares of 17,727 Amphastar Pharmaceuticals, Inc. $AMPH

Y Intercept Hong Kong Ltd acquired a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the 2nd quarter, according to its most recent filing with the Securities...

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Recommendation of "Moderate Buy" from Analysts

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven analysts that are covering the company, Marketbeat.com...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up Following Strong Earnings

Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up After Better-Than-Expected Earnings...

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings

The headline numbers for Amphastar (AMPH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates

Amphastar (AMPH) delivered earnings and revenue surprises of +20.78% and +3.96%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

AMPH
Amphastar Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMPH News

AMPHAmphastar Pharmaceuticals Inc